Strategic Growth West is expanding its Asia-Pacific footprint with new facilities in Singapore, China, and India, signaling increased demand for high-quality drug delivery systems and potential upsell of regional manufacturing capabilities and localized supply chain solutions.

SmartDose Expansion Development and manufacturing focus on SmartDose products, including the 10mL On-Body Delivery System, presents opportunities to cross-sell enhanced containment, compatibility testing, and larger-volume delivery expertise to pharma partners pursuing injectable therapies.

Digital & Transformation With leadership changes in digital and transformation, there is a window to position advanced digital manufacturing, data analytics, and enterprise platform services as core enablers for customers aiming to modernize production and traceability.

Global Partnerships West’s role as a long-standing partner to both established and emerging drug developers, plus its presence across 50 sites and billions of components shipped annually, opens avenues for strategic collaborations on containment, materials science, and prefilled systems for global programs.

Biologics & Prefillables Recent launches and China-focused efforts around prefillable syringe systems and silicone-free primary containers indicate opportunity to target biologics developers with compatible packaging solutions, sterile manufacturing processes, and regulatory-compliant containment options.